YULIANI, S. H. NANOPARTICLE AS THE STRATEGY FOR THE DEVELOPMENT OF SARS-COV-2 ANTIVIRAL DRUGS. International Journal of Applied Pharmaceutics, [S. l.], v. 13, n. 5, p. 33–43, 2021. DOI: 10.22159/ijap.2021v13i5.42604. Disponível em: https://journals.innovareacademics.in/index.php/ijap/article/view/42604. Acesso em: 22 nov. 2024.